Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

NORML

MAY 17, 2023

“These data indicate that the legal, regulated cannabis market is displacing the underground marketplace,” NORML’s Deputy Director Paul Armentano said. Over time, consumers are becoming more comfortable with and more reliant upon licensed retailers – who offer greater convenience, product quality, and safety.”

Retail 205

Retail Legalization Data Safety 205

Medicinal Genomics

JULY 14, 2022

The truth is that total count tests are not a good indicator of cannabis and hemp product safety for the following reasons: Pathogenic microbes may still be present Testing methods often do not agree Growers are discouraged from using beneficial microbes Growers are encouraged to use remediation. fumigatus, A.

Safety 92

Safety Research and Development Concentrates Food 92

Cannabis Law Report

DECEMBER 4, 2019

The North American College of Pharmaceutical Technology (NACPT) is conducting a pilot series of professionals in medical cannabis workshops, and we spent a day learning and discussing food safety, regulatory tech, processes and systems. Is the temperature and humidity control right for product safety? Source: [link].

Safety 75

Safety Supply Chain Environment Food 75

Cannabis Law Report

MAY 31, 2023

General Counsel Jonathan Miller Raises Concerns Regarding FDA’s Stance on CBD Regulation WASHINGTON D.C. — On the heels of last week’s U.S. Food and Drug Administration (FDA) webinar for hemp industry stakeholders, “A New Way Forward for Cannabidiol and Other Hemp Products,” U.S.

Safety 52

Safety Data CBD Hemp 52

Cannabis Law Report

JULY 29, 2021

According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Public health and safety programs. General funds.

Data 116

Data Legalization Education Programs 116

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. AIkido Pharma Inc.:

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

AUGUST 19, 2022

La Jolla, CA: The establishment of licensed cannabis retailers is not independently associated with an increase in traffic crashes, according to data published in the journal Health Economics.

Safety 52

Safety Retail Data Access 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

SpeedWeed

MARCH 21, 2021

As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. The post Largest Human Trial To Date Will Review Safety Of Full Spectrum Hemp Products appeared first on SpeedWeed. Read the entire article at The Fresh Toast.

Safety 52

Safety Hemp Extraction Sativa 52

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

MAY 26, 2022

This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link]. Tweet this.

Data 52

Data Access Business Retail 52

Cannabis Law Report

MARCH 21, 2020

Public Safety (PS) is supporting efforts to enforce the legalization and regulation of cannabis through activities to deter criminal activity and to help ensure that organized crime does not penetrate the legalized system.

Safety 88

Safety Research and Development Data Cannabis 88

SpeedWeed

AUGUST 25, 2021

Data shows that commercial drivers are consuming cannabis more than any other drug, even if it can ruin their career. Commercial drivers test positive for cannabis more often these days than any other drug, according to the latest data from the U.S. The data matches existing data on drivers in general.

Data 52

Data CBD Cannabis Safety 52

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 243

Cannabinoids Data Safety Patients 243

The Blunt Truth

JULY 18, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 98

DEA Data Decriminalization Legalization 98

NORML

MAY 19, 2020

The enactment of adult-use cannabis legalization laws in Colorado and Washington is associated with increased tourism in both states, according to data published in the Journal of Regional Analysis & Policy. Additional information appears in the NORML fact-sheet , “Marijuana Regulation: Impact on Health, Safety, and Economy.”

Legalization 324

Legalization Marijuana Data Policy 324

NORML

FEBRUARY 19, 2020

Jobs in the state-licensed cannabis industry rose 15 percent during the past 12 months, and the industry now employs over 243,000 full-time workers, according to data compiled by Leafly.com. Additional information is available in the NORML fact-sheet , ‘Marijuana Regulation: Impact on Health, Safety, Economy.’

Legalization 332

Legalization Marijuana Data Safety 332

NORML

FEBRUARY 11, 2020

The enactment of state-specific medical cannabis access laws is associated with a decline in workers’ compensation claims, according to data published in the journal Health Economics. ” They concluded: “Our findings add to the small, but growing, literature on the effects of MMLs on labor market outcomes.

Access 280

Access Safety Data Marijuana 280

Veriheal

JULY 25, 2023

Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. However, it is important to note that Quest Diagnostics amphetamines data does not separate prescribed medications like Adderall from illicit drug use. in 2021 and 4.3%

Safety 92

Safety Data Recreational Marijuana 92

Cannabis Law Report

NOVEMBER 2, 2021

This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or individual cannabinoids in 23 different patient populations, including autism , chronic pain , diabetes , fibromyalgia , migraine , and post-traumatic stress.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Cheri

MARCH 25, 2021

The FDA, which requested science-based data to help inform regulatory decisions for hemp-derived CBD products, has been informed by ValidCare investigators about the positive results of the study. Once completed, safety results of this study will be shared with participating brands and FDA. Read more about the study here. Pin This!

CBD 235

CBD Data Safety Tincture 235

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

The Blunt Truth

DECEMBER 3, 2019

In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly. Additionally, class actions continue to populate the federal docket based on third-party testing revealing that CBD supplements are not as advertised, only bolstering the FDA’s safety concerns.

Safety 68

Safety CBD Seed-To-Sale Food 68

Veriheal

AUGUST 24, 2023

Christopher Simpson, a deputy director at the Pacific Northwest Agricultural Safety and Health Center, believes that overall, the risk of DDE in cannabis is likely low. “To There just isn’t experimental data available,” Simpson said. There just isn’t experimental data available,” Simpson said.

Data 97

Data Safety Extraction Cannabis 97

Cannabis Law Report

JUNE 18, 2021

Crash rates spiked with the legalization of recreational marijuana use and retail sales in California, Colorado, Nevada, Oregon and Washington, a new study by the Insurance Institute for Highway Safety (IIHS) and another by the affiliated Highway Loss Data Institute (HLDI) show. Insurance Institute for Highway Safety.

Safety 66

Safety Legalization Marijuana Retail 66

Cannabis Law Report

FEBRUARY 24, 2022

A major observation describes a situation that may result in a risk to public health or public safety, or may involve fraud, or may increase the risk of diversion, prevent the detection of diversion or health risk. Health Canada may take enforcement actions to address non-compliance or to mitigate risks to public health or public safety.

Compliance 52

Compliance Compliance Data Safety 52

NORML

MARCH 5, 2019

The state-licensed cannabis industry gained over 64,000 new employees in 2018, and now employs over 200,000 full-time workers, according to data compiled by Whitney Economics and the online content provider Leafly.com. The full report is available online here.

Legalization 277

Legalization Marijuana Data Safety 277

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Clinical Trials 237

Clinical Trials Chronic Pain Cannabinoids Patients 237

Canna Law Blog

FEBRUARY 25, 2022

Exercise enforcement discretion review the safety data of a CBD dietary supplement consistent with the premarket safety review of a new dietary ingredient notification. Issue notice-and-comment rulemaking to establish that CBD is lawful under the FDCA.

CBD 81

CBD Safety Data Food 81

Cannabis Law Report

JULY 20, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

DECEMBER 14, 2019

. … An association of marijuana testing labs is calling on the state to release unredacted data from Nevada’s seed-to-sale tracking system amid assertions that certain unidentified labs are inflating THC content readings and giving fewer samples a failing grade in an apparent attempt to attract more business.

Seed-To-Sale 64

Seed-To-Sale Data Safety Dispensary 64